Albert Bourla

Pfizer CEO: Vaccine third dose 'likely' needed within 12 months

The head of Pfizer said in an interview aired on April 15 that people will "likely" need a third dose of his company's COVID-19 shot within six to 12 months of vaccination, while elsewhere defending the relatively higher cost of the jab.

CEO Albert Bourla also said annual vaccinations against the coronavirus may well be required.

BioNTech/Pfizer Vaccine Shows High Protection for Teens, Approval Expected

BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.

Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses", the companies said in a statement.

Pfizer CEO Albert Bourla's parents among the few Thessaloniki Jews to survive the Holocaust

Albert Bourla, Chairman and CEO of US pharmaceuticals company Pfizer, shared the story of his parents, Jews from Thessaloniki, and how they managed to be among the 2,000 survivors from a community of 50,000 nearly eradicated by the Holocaust.

Pfizer CEO says 'filled with emotion' as relative receives vaccine in Greece

Albert Bourla, the Greek chairman and chief executive of pharmaceutical giant Pfizer, took to social media on Monday to announce that his father-in-law just got vaccinated in Greece.

"This is my father-in-law, the 1st member of our family to receive his 1st dose of the vaccine," he said in a post on Twitter accompanied by a photo.

Pfizer’s Greek CEO laments ‘deeply disturbing’ events in Washington DC

Albert Bourla, the Greek chairman and chief executive of pharmaceutical giant Pfizer, has taken to social media to lament the "deeply disturbing" events that took place earlier this week in the American capital, when dozens of pro-Trump rioters stormed the US Capitol.

Pfizer CEO confident vaccine supply will exceed needs by end of 2021

Pfizer Inc's chief executive, Albert Bourla, said on Wednesday he was confident that by the end of 2021 there would be more vaccine doses than required to fight the Covid-19 pandemic.

His remarks came after Britain approved a vaccine produced by Pfizer and its German biotechnology partner BioNTech on Wednesday. The two companies say their vaccine is 95% effective.

Pages